Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.

Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, Linehan JM, Brandner S, Wadsworth JD, Hewitt P, Collinge J.

Lancet. 2006 Dec 9;368(9552):2061-7.

PMID:
17161728
2.

Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG.

Lancet. 2004 Feb 7;363(9407):417-21.

PMID:
14962520
3.

Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.

Hewitt PE, Llewelyn CA, Mackenzie J, Will RG.

Vox Sang. 2006 Oct;91(3):221-30.

PMID:
16958834
4.

Variant CJD and blood transfusion: are there additional cases?

Davidson LR, Llewelyn CA, Mackenzie JM, Hewitt PE, Will RG.

Vox Sang. 2014 Oct;107(3):220-5. doi: 10.1111/vox.12161. Epub 2014 Jun 11.

PMID:
24916465
5.

Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?

Chohan G, Llewelyn C, Mackenzie J, Cousens S, Kennedy A, Will R, Hewitt P.

Transfusion. 2010 May;50(5):1003-6. doi: 10.1111/j.1537-2995.2010.02614.x. Epub 2010 Mar 5.

PMID:
20230536
6.

A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions.

Gillies M, Chohan G, Llewelyn CA, MacKenzie J, Ward HJ, Hewitt PE, Will RG.

Vox Sang. 2009 Oct;97(3):211-8. doi: 10.1111/j.1423-0410.2009.01222.x. Epub 2009 Aug 6.

PMID:
19671123
7.

Variant Creutzfeldt-Jakob disease with extremely low lymphoreticular deposition of prion protein.

Mead S, Wadsworth JD, Porter MC, Linehan JM, Pietkiewicz W, Jackson GS, Brandner S, Collinge J.

JAMA Neurol. 2014 Mar;71(3):340-3. doi: 10.1001/jamaneurol.2013.5378.

8.

Recent advances in the pre-mortem diagnosis of Creutzfeldt-Jakob disease.

Collins S, Boyd A, Fletcher A, Gonzales MF, McLean CA, Masters CL.

J Clin Neurosci. 2000 May;7(3):195-202. Review.

PMID:
10833615
9.

Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay.

Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T, Lowe J, Mead S, Rudge P, Collinge J, Jackson GS.

Lancet. 2011 Feb 5;377(9764):487-93. doi: 10.1016/S0140-6736(10)62308-2.

PMID:
21295339
10.

Variant CJD. 18 years of research and surveillance.

Diack AB, Head MW, McCutcheon S, Boyle A, Knight R, Ironside JW, Manson JC, Will RG.

Prion. 2014;8(4):286-95. doi: 10.4161/pri.29237. Epub 2014 Nov 1. Review.

11.

Variant Creutzfeldt-Jakob disease: an update.

Ironside JW.

Folia Neuropathol. 2012;50(1):50-6. Review.

12.
13.

An overview of prion biology and the role of blood filtration in reducing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease.

Cervia JS, Sowemimo-Coker SO, Ortolano GA, Wilkins K, Schaffer J, Wortham ST.

Transfus Med Rev. 2006 Jul;20(3):190-206. Review.

PMID:
16787827
14.
15.

Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.

Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW.

Lancet. 2004 Aug 7-13;364(9433):527-9.

PMID:
15302196
16.

Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.

Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J.

Lancet. 2001 Jul 21;358(9277):171-80.

PMID:
11476832
17.

[Diagnosis of prion diseases].

Federspil PA, Federspil P, Plinkert PK.

HNO. 2002 Apr;50(4):327-31. German.

PMID:
12063690
18.

Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion.

Peden AH, Ritchie DL, Ironside JW.

Folia Neuropathol. 2005;43(4):271-8. Review.

19.

Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman.

Mead S, Joiner S, Desbruslais M, Beck JA, O'Donoghue M, Lantos P, Wadsworth JD, Collinge J.

Arch Neurol. 2007 Dec;64(12):1780-4.

PMID:
18071044
20.

Cost-effectiveness of prion filtration of red blood cells to reduce the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease in the Republic of Ireland.

Teljeur C, Flattery M, Harrington P, O'Neill M, Moran PS, Murphy L, Ryan M.

Transfusion. 2012 Nov;52(11):2285-93. doi: 10.1111/j.1537-2995.2012.03637.x. Epub 2012 Apr 9.

PMID:
22486387
Items per page

Supplemental Content

Write to the Help Desk